Login / Signup

The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database.

Masami TsuchiyaTaku ObaraMasafumi KikuchiNariyasu Mano
Published in: Cancer chemotherapy and pharmacology (2023)
This study provides insights into the current status of end-of-life chemotherapy and targeted therapy in Japan, using a large administrative claims database. The results of this study will inform future research on end-of-life chemotherapy and targeted therapy, and help develop strategies to improve the quality of life of patients with advanced cancer.
Keyphrases
  • current status
  • advanced cancer
  • locally advanced
  • public health
  • squamous cell carcinoma
  • risk factors
  • emergency department
  • climate change
  • health promotion